Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1998-04-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1006/BBRC.1998.8523PMID 9588192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells.

  1997cited by this paper
• Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy.

  1997cited by this paper
• Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles.

  1997cited by this paper
• Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure.

  1997cited by this paper
• Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.

  1997cited by this paper
• Protein oxidation in hemodialysis and kidney transplantation.

  1996cited by this paper
• Plasma glutathione peroxidase deficiency caused by renal dysfunction.

  1996cited by this paper
• Involvement of Hydrogen Peroxide in Collagen Cross-linking by High Glucose in Vitro and in Vivo*

  1996cited by this paper
• Advanced oxidation protein products as a novel marker of oxidative stress in uremia.

  1996cited by this paper
• Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.

  1996cited by this paper
• Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

  1996cited by this paper
• Cu/Zn-superoxide dismutase and glutathione peroxidase during aging.

  1995cited by this paper
• Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism.

  1994cited by this paper
• Human kidney proximal tubules are the main source of plasma glutathione peroxidase.

  1994cited by this paper
• Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.

  1994cited by this paper
• Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.

  1994cited by this paper
• Accumulation of Maillard reaction products in skin collagen in diabetes and aging.

  1993cited by this paper
• beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.

  1993cited by this paper
• Increased lipid peroxidation in patients on maintenance hemodialysis.

  1992cited by this paper
• Chromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects

  1992cited by this paper
• Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody.

  1992cited by this paper
• Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Studies with the model fructosamine, N epsilon-(1-deoxy-D-fructos-1-yl)hippuryl-lysine.

  1992cited by this paper
• Quantitative and qualitative changes of serum albumin in CAPD patients.

  1992cited by this paper
• Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure.

  1991cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper
• Hydrogen peroxide production during experimental protein glycation

  1990cited by this paper
• Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process.

  1989cited by this paper
• Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing.

  1988cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling.

  1988cited by this paper
• Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme.

  1987cited by this paper
• Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.

  1986cited by this paper
• Reevaluation of assay methods and establishment of kit for superoxide dismutase activity.

  1984cited by this paper
• Extracellular superoxide dismutase in human tissues and human cell lines.

  1984cited by this paper

• Mitochondria as a Source and a Target for Uremic Toxins

  2019cites this paper
• In vitro membrane damage induced by half-fin anchovy hydrolysates/glucose Maillard reaction products and the effects on oxidative status in vivo.

  2018cites this paper
• Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus

  2017cites this paper
• Antioxidant balance and accumulation of advanced glycation end products after the consumption of standard diets including Maillard reaction products from silver carp peptides.

  2016cites this paper
• Glycated Hemoglobin, Gastric Juice Nitric Oxide and Oxidative Stress in Diabetic Patients Infected by Helicobacter Pylori

  2015cites this paper
• Effects of long-term consumption of standard diets including glucose-lysine model glycated compounds on the antioxidant status of adult rats.

  2015cites this paper
• Antioxidant balance after long-term consumption of standard diets including bread crust glycated compounds by adult rats.

  2014cites this paper
• Carbonyl Stress in Uremia

  2013cites this paper
• Evaluation of glycemic control, gastric juice nitric oxide and oxidative stress in diabetic patients infected by Helicobacter pylori

  2011cites this paper
• Coffee constituents and modulation of antioxidant status in Caco-2 cells

  2010cites this paper
• Advanced glycation end‐products and the kidney

  2010cites this paper
• Oxidative stress in Alzheimer disease

  2009cites this paper
• Methylglyoxal increase in uremia with special reference to snakebite-mediated acute renal failure.

  2008cites this paper
• Increased Exhaled H2O2 and Impaired Lung Function in Patients Undergoing Bioincompatible Hemodialysis

  2007cites this paper
• Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes.

  2007cites this paper
• COMPARISON OF LEVELS OF NITRIC OXIDE, SUPEROXIDE DISMUTASE AND GLUTATHIONE PEROXIDASE OF GASTRIC JUICE IN INFECTED AND NON-INFECTED PATIENTS WITH HELICOBACTER PYLORI

  2006cites this paper
• Advanced Glycation and Advanced Oxidation Protein Products: The Effect of Peritoneal Dialysis

  2006cites this paper
• Advanced glycation end products and the kidney.

  2005cites this paper
• Advanced glycation end products and the kidney

  2005cites this paper
• Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy.

  2005cites this paper
• Oxidative stress and uremia

  2005cites this paper
• Importance of measuring products of non-enzymatic glycation of proteins.

  2005cites this paper
• Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis.

  2004cites this paper
• Carbonyl Stress and Diabetic Complications

  2003cites this paper
• Advanced glycation end products in uremia.

  2003cites this paper
• Influence of Maillard reaction products on DNA damage in human lymphocytes.

  2002cites this paper
• Plasma Pentosidine Levels Measured by a Newly Developed Method Using ELISA in Patients with Chronic Renal Failure

  2002cites this paper
• Advanced glycation end products in children with chronic renal failure and type 1 diabetes

  2002cites this paper
• Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes.

  2002cites this paper
• Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.

  2001cites this paper
• Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.

  2001cites this paper
• Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").

  2001cites this paper
• Reactive carbonyl compounds as uremic toxins.

  2001cites this paper
• Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism.

  2000cites this paper
• Advanced glycation end products: a Nephrologist's perspective.

  2000cites this paper
• Reduced Oxidative Stress in Hypoalbuminemic CAPD Patients

  2000cites this paper
• Relevance of oxidative and carbonyl stress to long-term uremic complications.

  2000cites this paper
• Nitric oxide inhibits the formation of advanced glycation end products.

  2000cites this paper
• Investigations on oxidative stress and therapeutical implications in dementia

  1999cites this paper
• Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".

  1999cites this paper
• Effect of a new vitamin E-coated membrane on glycoxidation during hemodialysis.

  1999cites this paper
• Pathogenic Role of Advanced Glycation End-Products (Ages): An Overview

  1999cites this paper